Jubilant Pharmova Statistics

Total Valuation

NSE:JUBLPHARMA has a market cap or net worth of INR 153.26 billion. The enterprise value is 173.15 billion.

Market Cap	153.26B
Enterprise Value	173.15B

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Aug 2, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	-0.30%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	64.51M

Valuation Ratios

The trailing PE ratio is 24.44.

PE Ratio	24.44
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	6.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	27.61
EV / Sales	2.45
EV / EBITDA	15.94
EV / EBIT	22.80
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.52
Debt / EBITDA	2.92
Debt / FCF	n/a
Interest Coverage	2.98

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.04%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	13.08M
Profits Per Employee	1.16M
Employee Count	5,399
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.94% in the last 52 weeks. The beta is 1.61, so NSE:JUBLPHARMA's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	+60.94%
50-Day Moving Average	1,003.24
200-Day Moving Average	963.70
Relative Strength Index (RSI)	46.96
Average Volume (20 Days)	415,420

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:JUBLPHARMA had revenue of INR 70.64 billion and earned 6.27 billion in profits. Earnings per share was 39.50.

Revenue	70.64B
Gross Profit	46.35B
Operating Income	7.30B
Pretax Income	7.21B
Net Income	6.27B
EBITDA	9.99B
EBIT	7.30B
Earnings Per Share (EPS)	39.50

Full Income Statement

Balance Sheet

The company has 10.77 billion in cash and 30.80 billion in debt, giving a net cash position of -20.03 billion.

Cash & Cash Equivalents	10.77B
Total Debt	30.80B
Net Cash	-20.03B
Net Cash Per Share	n/a
Equity (Book Value)	59.27B
Book Value Per Share	373.88
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.62%, with operating and profit margins of 10.33% and 8.88%.

Gross Margin	65.62%
Operating Margin	10.33%
Pretax Margin	10.20%
Profit Margin	8.88%
EBITDA Margin	14.14%
EBIT Margin	10.33%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.52%.

Dividend Per Share	5.00
Dividend Yield	0.52%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.13%
Shareholder Yield	0.65%
Earnings Yield	4.09%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on March 17, 2006. It was a forward split with a ratio of 5.

Last Split Date	Mar 17, 2006
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a